Sleep consolidates experience-dependent brain plasticity, but the precise cellular mechanisms mediating this process are unknown [1] . De novo cortical protein synthesis is one possible mechanism. In support of this hypothesis, sleep is associated with increased brain protein synthesis [2, 3] and transcription of messenger RNAs (mRNAs) involved in protein synthesis regulation [4, 5] . Protein synthesis in turn is critical for memory consolidation and persistent forms of plasticity in vitro and in vivo [6, 7] . However, it is unknown whether cortical protein synthesis in sleep serves similar functions. We investigated the role of protein synthesis in the sleep-dependent consolidation of a classic form of cortical plasticity in vivo (ocular dominance plasticity, ODP; [8, 9] ) in the cat visual cortex. We show that intracortical inhibition of mammalian target of rapamycin (mTOR)-dependent protein synthesis during sleep abolishes consolidation but has no effect on plasticity induced during wakefulness. Sleep also promotes phosphorylation of protein synthesis regulators (i.e., 4E-BP1 and eEF2) and the translation (but not transcription) of key plasticity related mRNAs (ARC and BDNF). These findings show that sleep promotes cortical mRNA translation. Interruption of this process has functional consequences, because it abolishes the consolidation of experience in the cortex.
Sleep consolidates experience-dependent brain plasticity, but the precise cellular mechanisms mediating this process are unknown [1] . De novo cortical protein synthesis is one possible mechanism. In support of this hypothesis, sleep is associated with increased brain protein synthesis [2, 3] and transcription of messenger RNAs (mRNAs) involved in protein synthesis regulation [4, 5] . Protein synthesis in turn is critical for memory consolidation and persistent forms of plasticity in vitro and in vivo [6, 7] . However, it is unknown whether cortical protein synthesis in sleep serves similar functions. We investigated the role of protein synthesis in the sleep-dependent consolidation of a classic form of cortical plasticity in vivo (ocular dominance plasticity, ODP; [8, 9] ) in the cat visual cortex. We show that intracortical inhibition of mammalian target of rapamycin (mTOR)-dependent protein synthesis during sleep abolishes consolidation but has no effect on plasticity induced during wakefulness. Sleep also promotes phosphorylation of protein synthesis regulators (i.e., 4E-BP1 and eEF2) and the translation (but not transcription) of key plasticity related mRNAs (ARC and BDNF). These findings show that sleep promotes cortical mRNA translation. Interruption of this process has functional consequences, because it abolishes the consolidation of experience in the cortex.
Results and Discussion
Protein Synthesis during Sleep, But Not Wake, Is Important for Ocular Dominance Plasticity Ocular dominance plasticity (ODP) refers to plastic changes in visual cortical circuits triggered by transiently blocking patterned vision in one eye (monocular deprivation, MD) [8, 9] . ODP appears to involve Hebbian and nonHebbian forms of synaptic plasticity [10] , many of which require de novo protein synthesis to be consolidated [11] . We have previously shown that ODP can be divided into an induction phase (during waking) and a consolidation phase (during sleep) [9, 12] . What is not known, however, is the relative role of protein synthesis in the waking and sleeping phases of ODP.
To address this issue, we inhibited protein synthesis in visual cortex (V1) with rapamycin (RAPA), which interferes with the Raptor/mTOR complex (mTORC1) [13] , preventing mTORC1-mediated cap-dependent translation initiation [14] . mTORC1 is crucial for consolidation of several forms of plasticity [15] , but its role in ODP has not been investigated. We first determined whether mTORC1-mediated translation was required for the sleep-dependent consolidation of ODP. These animals underwent 6 hr of MD (while awake) and then were allowed to sleep ad lib for 6 hr during which time RAPA or vehicle (VEH) were intracortically infused in V1 (MD + sleep in Figure 1A) . The animals were then immediately assessed for changes in ODP using microelectrode recording of single V1 neurons (see Supplemental Experimental Procedures available online).
When infused during post-MD sleep, RAPA inhibited mTORC1 signaling as measured by phosphorylation of its direct downstream target; eukaryotic initiation factor 4E (eIF4E)-binding protein 1 (4E-BP1) ( Figure 1B ; see Supplemental Experimental Procedures: Validation of RAPA Efficacy). RAPA also reduced cortical expression of several plasticity related proteins (ARC, BDNF, PSD-95) and the translation factor eukaryote elongation factor 1A (eEF1A) (Figure 1B) . RAPA also completely abolished ODP consolidation. Microelectrode recording and corresponding ocular dominance (OD) histograms [16] showed that the normal sleepdependent shift in visual responses toward the nondeprived eye (NDE) did not occur in neurons infused with RAPA. Sleep following MD in the VEH-infused animals increased the proportion of cells more strongly activated by stimulation of the NDE (OD scores of 1-3); this did not occur in cells infused with RAPA ( Figure 1C ). This was confirmed using the nondeprived bias index (NBI), a weighted average of the OD histogram [9, 12, 16] (Supplemental Experimental Procedures). The NBI, which ranges from 0.5 (equal dominance of both eyes) to 1 (total dominance by the NDE), showed that the effects of sleep on ODP were abolished in RAPA infused neurons ( Figures 1D and 1E ). As shown in Table S1 , RAPA prevented the normal sleep-dependent potentiation of NDE circuits and depression of deprived-eye (DE) circuits [12] . This indicated that both plastic changes require sleep-dependent protein synthesis.
These results are unlikely explained by nonspecific effects of RAPA. First, RAPA is highly selective for mTORC1 rather than mTORC2, the mTOR complex that influences cell survival and cytoskeletal organization [14] . However, because prolonged exposure to RAPA might also alter mTORC2 function [17] , we inactivated a downstream mediator of mTORC2 function (Akt; [18] ). The selective Akt inhibitor (LY294002) had no effect on ODP consolidation ( Figures S1D and S1E ). This result is consistent with previous findings indicating that downstream targets of mTORC2 (i.e., PKC) are not essential for ODP [19] . Second, RAPA had no effect on ongoing neuronal (EEG) activity or sleep behavior and did not produce abnormalities in sensory processing in V1 neurons (Figures S1A and S1C; Table S1 ).
To further examine the role of protein synthesis in ODP consolidation, we next infused cycloheximide (CHX) during post-MD sleep. CHX disrupts the translocation-elongation step of protein synthesis and globally reduces cortical protein synthesis in vivo [20] . CHX also completely blocked ODP consolidation (n = 3 hemispheres, NBI: RAPA, 0.56 6 0.03; CHX, 0.59 6 0.04, p > 0.05, t test). In contrast to RAPA, CHX produced abnormalities in cat V1 responses compared to control animals with normal binocular vision (Table S1 ). This may be related to neurotoxic effects of CHX, which not only globally reduces protein synthesis throughout the cell but can also inhibit DNA replication [21] . We therefore used RAPA for all protein-synthesis inhibition experiments.
We next determined whether mTORC1 was also required for the induction of ODP during wakefulness. These animals underwent 6 hr of MD while awake combined with V1 infusion of VEH or RAPA (MD only in Figure 1A ). Consistent with previous findings [9, 12] , 6 hr of MD in the awake cat induced a small but significant shift in OD in favor of the NDE. This form of plasticity, however, was unaffected by RAPA ( Figures 1C-1E ). These results demonstrate that, in contrast to sleepdependent consolidation, protein synthesis is not required for the induction of ODP during wakefulness.
Sleep Promotes Translation Initiation
To further explore the relationship between sleep and messenger RNA (mRNA) translation, we measured sleepdependent changes in translation regulation at the initiation (4E-BP1) and elongation (eukaryotic elongation factor 2; eEF2) steps. Phosphorylation of 4E-BP1 by mTORC1 relieves its inhibition on eIF4E; the first and crucial step in cap-dependent translation initiation [14] . 4E-BP1 and eEF2 have also been directly implicated in persistent forms of synaptic plasticity and memory [6, 11] . However, their roles in sleep-dependent cortical plasticity in vivo have not been explored.
Using western blot, we measured changes in the phosphorylation state of both translation factors in synaptoneurosomal (SN, enriched in synaptic proteins; Figure 2B ) and total (TOT, whole cell extract) protein fractions (see Supplemental Experimental Procedures) from V1. SN fractions were examined because rapid translation of preexisting pools of synaptic mRNAs mediates several forms of persistent plasticity in vitro [22] , but this has not been explored in sleep-dependent plasticity. Using an experimental design similar to the one used for RAPA infusion, cats were divided into the following groups: 6 hr of MD only (in awake cats) or 6 hr of MD combined with 1, 2, or 6 hr of ad lib sleep in complete darkness (Figure 2A) . Control groups consisted of animals treated exactly the same except that binocular vision was left intact (noMD). This group would determine whether molecular changes observed after MD were specifically due to synaptic remodeling or, instead, processes generally promoted either by wake or sleep (see Tables S2-S4 for details on group formation) [12] . Following these procedures, the animals were sacrificed and V1 cortices harvested.
We found a simultaneous increase in phosphorylation of 4E-BP1 and eEF2 after 1-2 hr of sleep. These changes appeared to be compartmentalized; increased translation initiation (i.e., increased p-4E-BP1) occurred preferentially in SN fractions ( Figure 2C ) and decreased protein elongation (i.e., increased p-eEF2) occurred preferentially in TOT protein fractions and specifically in the MD group ( Figure 2D ). We also found a 36.5% increase in the phosphorylation (at Ser209) of the key cap-dependent initiation factor eIF4E [14] after 1 hr of sleep in the MD group, but this did not reach significance (data not shown). When the samples shown in Figure 1B were tested for eEF2, we found no effect of RAPA on eEF2 phosphorylation (RAPA far site: 1.05 6 0.05 versus RAPA near site: 1.18 6 0.11, p = 0.3, n = 10, t test). This suggests that in the remodeling visual cortex, eEF2 is not a downstream target of mTORC1 [23] and is probably activated by another pathway. ERK for example is also activated in post-MD sleep [12] and can also phosphorylate eEF2 [24] .
These results indicate that sleep promotes translation initiation (i.e., p-4E-BP1) and when V1 is triggered to remodel, this is accompanied by a decrease in protein elongation (i.e., p-eEF2). Similar coregulation and compartmentalization of initiation and elongation factors are also reported following in vivo BDNF-mediated long-term potentiation (LTP) [25] and during long-term facilitation in Aplysia [26] , suggesting that this is a conserved mechanism in persistent forms of plasticity. In addition, this may also enhance the translation of specific pools of mRNAs [27] . This is because decreasing the elongation step (via eEF2 phosphorylation) may shift the rate-limiting step in protein synthesis away from initiation toward elongation, which increases the translation of what are termed ''poorly initiated proteins'' (e.g., ARC) [27] . Our findings indicate that these latter events may be specifically promoted by sleep.
Translation and Transcription of ARC and BDNF Are Divided across Wake and Sleep
Our results suggest that mRNAs important for plasticity are translated during sleep. We therefore examined sleepdependent changes in the translation (and for comparison, transcription) of two mRNAs centrally involved in Hebbian and nonHebbian forms of plasticity [28, 29] and which were reduced (as proteins) by RAPA during sleep ( Figure 1B) : ARC (also known as Arg3.1) and BDNF. These mRNAs are also translated in LTP (BDNF and ARC) or long-term depression (LTD) protocols (ARC) that trigger phosphorylation of mTORC1 and/or eEF2 [30, 31] and are important for ODP [32, 33] . We also examined the translation and transcription of aCaMKII (i.e., CAMK2A) and GLURI (i.e., GRIA1), which, at a protein level, were unaffected by intracortical RAPA infusion ( Figure S3A ). All four mRNAs have also been shown to be trafficked to synapses where they remain untranslated until synaptic plasticity is induced [22] . Using western blot and quantitative PCR (qPCR), we measured sleep-dependent changes in the transcription and translation of ARC, BDNF, aCaMKII, and GLURI from cortices used in Figure 2 .
In agreement with studies in adult rodents [4, 34] , ARC and BDNF mRNA transcript levels were reduced after sleep (in both noMD and MD groups, Figure 3A) . In contrast to these studies, the corresponding proteins were transiently but significantly upregulated in the first (BDNF: MD + sleep; Figure 3C ) and second hr (ARC: noMD + sleep and MD + sleep; Figure 3B ) of sleep, declining only after 6 hr ( Figures 3B and 3C ). This corresponded to the period of enhanced translation initiation in sleep (Figure 2 ) These findings indicate that the transcription and translation of ARC and BDNF do not always occur in parallel during sleep and that the first few hours of sleep may be a time of accelerated protein synthesis. In contrast, there were only modest changes in aCaMKII and GLURI transcription and translation across sleep and wake ( Figure S3B ). These latter results indicate that not all transcripts are regulated in a state-dependent fashion and further suggest that only a subset of proteins is actively translated during sleep.
Translational Events Are Promoted by Sleep; Transcription by Patterned Vision during Wakefulness
We next determined whether the reduction in mRNAs observed after sleep was merely an indirect effect of reducing visual input to V1 rather than an active repression of transcription. An indirect effect was suggested by the observation that ARC and BDNF mRNAs were reduced by MD in awake animals (relative to noMD animals; Figure 3A ). Because MD reduces visual drive to V1 and reducing visual input decreases mRNA transcription in V1 [35] , we hypothesized that decreases observed after sleep might also reflect a decrease in visual input during sleep. To explore this possibility, we examined the effects of 6 hr of binocular deprivation (BD only; Figure 4A ; Supplemental Experimental Procedures) in awake cats, which does not trigger ODP [8] , on ARC and BDNF mRNAs. We also examined FOS (c-fos) mRNA, because expression of this immediate early gene is a widely used marker of activity-dependent transcription [36] and because FOS also decreases during sleep ( Figure S4A ). Consistent with our hypothesis, 6 hr of BD in the awake cat reduced transcription of ARC, BDNF, and FOS to a level observed after 6 hr of sleep ( Figure 4B ; Figure S4B ). This suggests that sleeprelated decreases in ARC, BDNF, and FOS (at least within the visual cortex) may be passive epiphenomena of sleep unrelated to experience-dependent plasticity. (Table S3 for details) . All values are represented as means 6 SEM.
We then determined whether the protein changes shown in Figures 2 and 3 were sleep-dependent or merely time-dependent. We found that the largest changes in proteins observed after sleep did not occur when animals were instead kept awake 1 hr after MD (MD + 1 hr SD; Figures 4A, 4C, and 4D) . Increases in eEF2 and SN 4E-BP1 phosphorylation observed after sleep did not occur in the MD + 1 hr SD group ( Figure 4C ). This was also true for BDNF, where increases in TOT and SN fractions were no longer significant compared to wakefulness ( Figure 4D ). One hr of SD also significantly decreased ARC protein amounts compared to both the MD + 1 hr sleep and MD-only group ( Figure 4C ). Because eEF1A and PSD-95 were also reduced by RAPA during post-MD sleep ( Figure 1B) , we examined a subset of these samples for these proteins. Whereas there were no differences between MD and noMD conditions, when grouped together as wake only (MD only and noMD only), sleep (MD + 1 hr sleep and noMD + 1 hr sleep), and sleep-deprived (MD + 1 hr SD), there was a significant increase (80.34%) in PSD-95 synaptic content after sleep, which was significantly reduced by 55.4% in the sleepdeprived group ( Figure S4D ).There was no effect of vigilance state on eEF1A synaptic content. Taken together, these results indicated that protein changes observed after sleep in Figures  2 and 3 were sleep-dependent.
In summary, we show that sleep promotes cortical mRNA translation and interruption of this process prevents the consolidation of a canonical form of cortical plasticity in vivo. These findings are novel for the following reasons. First, although protein synthesis has been previously shown to be necessary for ODP [20] , we now show that this process specifically occurs during sleep. Second, although it is known that sleep is associated with heightened brain protein synthesis [2, 3, 5] , ours is the first demonstration that this serves an important cortical function (i.e., consolidating experience). Third, our findings suggest that the induction of ODP during wakefulness and its subsequent consolidation during sleep involve different cellular mechanisms. Protein synthesis is essential for plastic changes that occur during sleep but unnecessary for plasticity induced during wake. Lastly, our findings demonstrate that although experience is required for the transcription of key plasticity-related mRNAs, their translation into protein requires sleep. This may represent a sleep-dependent mechanism that converts labile plastic changes into more permanent forms.
Experimental Procedures Intracortical Infusion Experiments and Drugs
All cats underwent a standard design to induce ODP as described previously [9] . Drugs (rapamycin [150 mM], cycloheximide [6 mM], or LY294002 [LY29, 5 mM]) and VEH were infused intracortically at 0.25 ml/min in V1 by mean of an indwelling cannula. See Table S2 and Supplemental Experimental Procedures for details on group formation and single-unit recordings. All animals used in this study were obtained from our colony. All experimental procedures in animals were approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Sleep Analyses
Polysomnography was used to verify that animals in all groups were equally awake during the enforced waking period and equally asleep during the subsequent ad lib sleep period. See Figures S1 and S2 and Supplemental Experimental Procedures for additional details on sleep analysis.
Protein and mRNA Measures
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